NORTHVALE, N.J.--(BUSINESS WIRE)--Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today received the initial order of 20,000 SofPulse® devices from Allergan, Inc. (NYSE: AGN), its exclusive distribution partner for Ivivi’s SofPulse® line of products worldwide in the aesthetic and bariatric medical procedure markets. Allergan has initiated marketing efforts for the SofPulse® line of products and its product launch is expected to be completed by the end of calendar 2007.
